Free Newsletter
Top 20 Biotech Venture Capital Deals of 2009
With the help of data provided by the National Venture Capital Association, our sister pub FierceBiotech has put together a list of last year's top biotech venture capital deals. 2009 was an incredibly difficult year for biotech companies to raise venture funding, as the financial crisis caused firms to become more cautious with their money. But for companies with groundbreaking technology and exciting programs, there was still money to be had. Take a look at this list of the top 20 U.S. companies that raised big money in 2009. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: